Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy

This virtual conference will explore a seemingly paradoxical approach to cancer therapy, based on the deliberate hyper-activation of cancer-relevant signalling pathways. Accumulating evidence suggests that this leads to cell death caused by a further activation of cellular stress responses. Target audience: Scientists in academia and industry who are interested in a fundamentally and radically different approach to cancer therapy.